A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea

被引:57
作者
Abad, Cybele Lara R. [1 ]
Safdar, Nasia [2 ]
机构
[1] Univ Philippines Manila, UP Philippine Gen Hosp, Dept Med, Sect Infect Dis, Manila, Philippines
[2] Univ Wisconsin, Dept Med, Div Infect Dis, William S Middleton Mem Vet Hosp, Madison, WI 53706 USA
关键词
C. difficile infection; Antibiotic-associated diarrhea; Diagnosis; Treatment; Prevention; DISEASE SURVEILLANCE; ANTIMICROBIAL AGENT; ORAL VANCOMYCIN; DOUBLE-BLIND; RECURRENT; PREVENTION; SUSCEPTIBILITY; EPIDEMIOLOGY; FIDAXOMICIN; MICROBIOTA;
D O I
10.1016/j.gtc.2021.02.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:323 / 340
页数:18
相关论文
共 87 条
[1]  
Alam S, 2009, INDIAN PEDIATR, V46, P491
[2]   C difficile-a rose by any other name... [J].
不详 .
LANCET INFECTIOUS DISEASES, 2019, 19 (05) :449-449
[3]   Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus [J].
Asha, N. J. ;
Tompkins, D. ;
Wilcox, M. H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2785-2791
[4]   SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model [J].
Baines, S. D. ;
Crowther, G. S. ;
Freeman, J. ;
Todhunter, S. ;
Vickers, R. ;
Wilcox, M. H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) :182-189
[5]   Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study [J].
Barbut, F. ;
Day, N. ;
Bouee, S. ;
Youssouf, A. ;
Grandvoinnet, L. ;
Lalande, V. ;
Couturier, J. ;
Eckert, C. .
CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (05) :588-594
[6]   Clostridium difficile infection in Europe: a hospital-based survey [J].
Bauer, Martijn P. ;
Notermans, Daan W. ;
van Benthem, Birgit H. B. ;
Brazier, Jon S. ;
Wilcox, Mark H. ;
Rupnik, Maja ;
Monnet, Dominique L. ;
van Dissel, Jaap T. ;
Kuijper, Ed J. .
LANCET, 2011, 377 (9759) :63-73
[7]   Treatment and prevention of antibiotic associated diarrhea [J].
Bergogne-Bérézin, E .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (04) :521-526
[8]   The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact [J].
Borren, Nienke Z. ;
Ghadermarzi, Shadi ;
Hutfless, Susan ;
Ananthakrishnan, Ashwin N. .
PLOS ONE, 2017, 12 (05)
[9]   Onset of symptoms and time to diagnosis of Clostridium difficile -: Associated disease following discharge from an acute care hospital [J].
Chang, Heidi T. ;
Krezolek, Dorota ;
Johnson, Stuart ;
Parada, Jorge P. ;
Evans, Charlesnika T. ;
Gerding, Dale N. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08) :926-931
[10]   In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile [J].
Corbett, D. ;
Wise, A. ;
Birchall, S. ;
Warn, P. ;
Baines, S. D. ;
Crowther, G. ;
Freeman, J. ;
Chilton, C. H. ;
Vernon, J. ;
Wilcox, M. H. ;
Vickers, R. J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) :1751-1756